vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $117.7M, roughly 1.1× Resolute Holdings Management, Inc.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -1.5%, a 4.8% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $7.6M).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.
NATR vs RHLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $117.7M |
| Net Profit | $4.1M | $-1.7M |
| Gross Margin | 72.5% | 55.7% |
| Operating Margin | 4.3% | 30.2% |
| Net Margin | 3.3% | -1.5% |
| Revenue YoY | 4.7% | — |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $117.7M | ||
| Q3 25 | $128.3M | $120.9M | ||
| Q2 25 | $114.8M | $119.6M | ||
| Q1 25 | $113.2M | $103.9M | ||
| Q4 24 | $118.2M | — | ||
| Q3 24 | $114.6M | — | ||
| Q2 24 | $110.6M | — | ||
| Q1 24 | $111.0M | — |
| Q4 25 | $4.1M | $-1.7M | ||
| Q3 25 | $5.3M | $-231.0K | ||
| Q2 25 | $5.3M | $-611.0K | ||
| Q1 25 | $4.7M | $-3.4M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 72.5% | 55.7% | ||
| Q3 25 | 73.3% | 59.0% | ||
| Q2 25 | 71.7% | 57.5% | ||
| Q1 25 | 72.1% | 52.5% | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 30.2% | ||
| Q3 25 | 7.0% | 34.3% | ||
| Q2 25 | 3.7% | 34.0% | ||
| Q1 25 | 5.4% | 24.7% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.2% | — |
| Q4 25 | 3.3% | -1.5% | ||
| Q3 25 | 4.2% | -0.2% | ||
| Q2 25 | 4.6% | -0.5% | ||
| Q1 25 | 4.2% | -3.2% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | $0.23 | $-0.20 | ||
| Q3 25 | $0.30 | $-0.03 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.25 | $-0.39 | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $205.5M |
| Total DebtLower is stronger | — | $169.8M |
| Stockholders' EquityBook value | $161.6M | $6.5M |
| Total Assets | $261.1M | $333.4M |
| Debt / EquityLower = less leverage | — | 26.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $205.5M | ||
| Q3 25 | $95.6M | $148.0M | ||
| Q2 25 | $81.3M | $99.9M | ||
| Q1 25 | $86.5M | $71.0M | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $6.5M | ||
| Q3 25 | $166.7M | $10.8M | ||
| Q2 25 | $163.7M | $9.6M | ||
| Q1 25 | $167.1M | $8.9M | ||
| Q4 24 | $161.0M | — | ||
| Q3 24 | $162.6M | — | ||
| Q2 24 | $156.4M | — | ||
| Q1 24 | $159.7M | — |
| Q4 25 | $261.1M | $333.4M | ||
| Q3 25 | $264.8M | $293.2M | ||
| Q2 25 | $254.9M | $253.3M | ||
| Q1 25 | $252.7M | $214.3M | ||
| Q4 24 | $240.9M | — | ||
| Q3 24 | $245.3M | — | ||
| Q2 24 | $235.8M | — | ||
| Q1 24 | $247.3M | — |
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $196.1M |
| Free Cash FlowOCF − Capex | $7.6M | $189.2M |
| FCF MarginFCF / Revenue | 6.1% | 160.8% |
| Capex IntensityCapex / Revenue | 1.9% | 5.8% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $313.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $196.1M | ||
| Q3 25 | $18.5M | $59.6M | ||
| Q2 25 | $4.3M | $48.9M | ||
| Q1 25 | $2.6M | $18.4M | ||
| Q4 24 | $12.2M | — | ||
| Q3 24 | $9.6M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $2.2M | — |
| Q4 25 | $7.6M | $189.2M | ||
| Q3 25 | $16.8M | $58.6M | ||
| Q2 25 | $3.0M | $47.5M | ||
| Q1 25 | $1.5M | $17.8M | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | 6.1% | 160.8% | ||
| Q3 25 | 13.1% | 48.5% | ||
| Q2 25 | 2.6% | 39.7% | ||
| Q1 25 | 1.3% | 17.1% | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | -1.4% | — |
| Q4 25 | 1.9% | 5.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 1.2% | 1.2% | ||
| Q1 25 | 1.0% | 0.6% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RHLD
Segment breakdown not available.
